Skip to content
Bacampicillin
Spectrobid (bacampicillin) is a small molecule pharmaceutical. Bacampicillin was first approved as Spectrobid on 1982-01-01. It is used to treat escherichia coli infections, gonorrhea, haemophilus infections, infectious skin diseases, and listeriosis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bacampicillin hydrochloride
Tradename
Company
Number
Date
Products
SPECTROBIDMylanN-050520 DISCN1982-01-01
2 products
SPECTROBIDMylanN-050556 DISCN1982-03-23
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
escherichia coli infectionsEFO_1001318D004927B96.20
gonorrheaDOID_7551D006069A54
haemophilus infectionsEFO_1001127D006192—
infectious skin diseases—D012874—
listeriosisEFO_0007347D008088A32
proteus infectionsEFO_1001130D011512—
respiratory tract infections—D012141J06.9
salmonella infectionsEFO_1001418D012480A02.9
soft tissue infections—D018461—
staphylococcal infections—D013203A49.01
Show 3 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01C: Beta-lactam antibacterials, penicillins
— J01CA: Penicillins with extended spectrum
— J01CA06: Bacampicillin
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neonatal sepsisD000071074HP_0040187————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBACAMPICILLIN
INNbacampicillin
Description
Bacampicillin (INN) is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability.
Classification
Small molecule
Drug classpenicillins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C
Identifiers
PDB—
CAS-ID50972-17-3
RxCUI—
ChEMBL IDCHEMBL1583
ChEBI ID2968
PubChem CID39849
DrugBankDB01602
UNII ID8GM2J22278 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 200 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
4 adverse events reported
View more details